Stellate ganglion block (SGB) is believed to modify the pathologic sympathetic pain response and has been commonly used to treat complex regional pain syndrome. We report successful treatment of cancer-related facial pain with SGB in three patients, suggesting a possible sympathetic pain-related mechanism. All patients exhibited clinically significant improvement of pain 12 weeks following the procedure. SGB should be considered a palliative pain treatment option in cancer-related facial pain.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241335 | PMC |
| http://dx.doi.org/10.1089/pmr.2020.0042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Determining the perceptions and practices of oncologists regarding venous thromboembolism risk assessment in ambulatory cancer patients: A qualitative study.
PLoS One
January 2025
Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
Cancer-associated thrombosis (CAT) can increase morbidity and mortality for cancer patients. Therefore, guidelines recommend predicting VTE risk and thromboprophylaxis for high-risk patients. Many studies critique oncologists' adherence to thromboprophylaxis guidelines for cancer patients.
View Article and Find Full Text PDFDiscrimination, Violence, Mental Health, and Substance Use by Age and Cancer History Among LGBTQ+ Individuals.
J Adolesc Young Adult Oncol
January 2025
Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Young adult (YA) LGBTQ+ cancer survivors face inequities and unmet needs that impact their well-being. However, the impact of age and cancer among LGBTQ+ individuals have not been adequately assessed. The North Carolina LGBTQ+ Health Needs Assessment survey, conducted at local Pride events, aimed to collect data to describe the well-being of LGBTQ+ people in NC.
View Article and Find Full Text PDFDuration of Breastfeeding and Risk Reduction of Breast Cancer among Mothers Who Have Ever Breastfed: A Case-Control Study Conducted in Bahir Dar, Ethiopia.
Breast J
January 2025
Malaria Alert Centre Kamuzu University of Health Sciences, Private Bag 360, Chichiri, Blantyre 3, Malawi.
Introduction: Breast cancer is currently the most frequently detected cancer in women and the primary cause of cancer-related deaths globally. The incidence of breast cancer has significantly increased in countries across sub-Saharan Africa, counting Ethiopia. There are multiple determinants of breast cancer, a few of these can be changeable whereas others are not.
View Article and Find Full Text PDFExosomes in esophageal cancer: a promising frontier for liquid biopsy in diagnosis and therapeutic monitoring.
Front Pharmacol
December 2024
Department of Thoracic Surgery, Organ Transplantation Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Esophageal cancer is a common and lethal digestive system malignancy, and both treatment efficacy and patient survival rates face significant challenges. In recent years, exosomes have emerged as crucial mediators of intercellular communication, demonstrating tremendous clinical potential, particularly in the diagnosis, treatment, and prognostic evaluation of esophageal cancer. These exosomes not only serve as biomarkers for early diagnosis and prognosis but also modulate tumor growth, metastasis, and drug resistance by delivering bioactive molecules.
View Article and Find Full Text PDFExploring the Relationship Between Dietary Phytochemical Index and Chemotherapy-Related Symptoms: Insights From a Cross-Sectional Study.
Food Sci Nutr
December 2024
Faculty of Health Sciences, Department of Nutrition and Dietetics Yeditepe University Istanbul Türkiye.
Phytochemicals may confer substantial benefits in alleviating chemotherapy-related symptoms. This cross-sectional study aimed to determine the role of dietary phytochemicals on treatment-related symptoms in patients receiving chemotherapy. Data including demographic variables, anthropometric measures such as weight and height, 3-day food record, and Nightingale Symptom Assessment Scale (N-SAS), a composite measure of patients' chemotherapy-related symptoms, were gathered via face-to-face interviews.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!